<DOC>
	<DOCNO>NCT02021279</DOCNO>
	<brief_summary>The primary objective study assess safety effectiveness MatriStem Pelvic Floor Matrix compare native tissue repair treatment pelvic organ prolapse . Patients evaluate throughout 3 year follow-up period .</brief_summary>
	<brief_title>ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair , Comparative Study</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>Subject 's lead edge POP beyond hymen . At beyond hymen define POPQ score Ba ≥ 0 Bp ≥ 0 C ≥ 0 ( prolapse apical compartment alone ) C ≥ ½ total vaginal length ( multicompartment prolapse include apical compartment ) . Subject seek surgical intervention symptomatic POP , define experience symptom vaginal bulge pelvic heaviness . Vaginal bulge pelvic heaviness consider present subject respond `` yes '' ( ≥1 ) PFDI20 , question 3 . Subject subject 's legally authorized representative willing provide write informed consent . Subject willing able comply followup regimen . Subject know hypersensitivity porcinebased material ( relevant subject MatriStem Pelvic Floor Matrix Group ) . Subject pregnant plan become pregnant study . Subject active chronic systemic infection include gynecologic infection , urinary tract infection ( UTI ) , tissue necrosis . Subject know neurologic medical condition affect bladder function ( e.g . multiple sclerosis , spinal cord injury , stroke residual neurologic deficit ) . Subject chronic systemic pain syndrome ( e.g . fibromyalgia , painful bladder syndrome ) . Subject systemic connective tissue disease ( e.g. , scleroderma , systemic lupus erythematous ( SLE ) , Marfans syndrome , Ehlers Danhlos , collagenosis , polymyositis polymyalgia rheumatica ) . Subject uncontrolled diabetes mellitus ( DM ) . Subject history pelvic organ cancer ( e.g . uterine , ovarian , bladder , cervical ) . Subject prior currently undergo radiation , laser therapy , chemotherapy pelvic area . Subject take systemic steroid ( within last month ) , immunosuppressive immunomodulatory treatment ( within last 3 month ) . Subject seek obliterative vaginal surgery treatment POP ( colpoclesis ) . Subject able conform modify dorsal lithotomy position . Subject currently participate plan participate another device drug study study . Subject plan undergo concurrent surgical treatment prolapse use mesh MatriStem Pelvic Floor Matrix .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pelvic organ prolapse</keyword>
	<keyword>MatriStem</keyword>
	<keyword>pelvic floor matrix</keyword>
	<keyword>ACell</keyword>
	<keyword>native tissue repair</keyword>
</DOC>